Tag: DynamX

Elixir Medical to Present 9 and 12-Month Clinical and Imaging Data for the DynamX Bioadaptor, Showcasing the Next Frontier Beyond Stenting at EuroPCR 2019

MILPITAS, Calif.–(BUSINESS WIRE)–Elixir Medical Corporation, a developer of products that combine state-of-the-art medical devices with advanced pharmaceuticals, announced today that it will release at EuroPCR in Paris 9 and 12-month clinical and imaging data for the DynamX™ Novolimus-eluting Bioadaptor System, a next-generation coronary intervention system designed to treat blocked arteries […]